Intranasal Human Recombinant Modified Glucagon-Like Peptide-1: High Antihyperglycemic Activity and Duration of Action in Mice
Crossref DOI link: https://doi.org/10.1007/s10517-020-04822-9
Published Online: 2020-06-03
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rykalina, N. V.
Askerova, E. V.
Bulushova, N. V.
Kozlov, D. G.
Text and Data Mining valid from 2020-05-01
Version of Record valid from 2020-05-01
Article History
Received: 12 September 2019
First Online: 3 June 2020